| Structure |
Chemical Name |
CAS |
MF |
 |
Rosuvastatin Impurity 82 |
|
|
 |
Dapagliflozin Impurity 19 |
1469910-84-6 |
C29H33ClO10 |
 |
Moxifloxacin impurity (20) |
|
|
 |
Cefazolin USP Impurity B |
|
|
 |
Pregabalin Impurity 10 |
69680-50-8 |
C7H11NO3 |
 |
(2S)-N-(2,6-ジメチルフェニル)-1-イソプロピルピペリジン-2-カルボアミド |
265120-58-9 |
C17H26N2O |
 |
(3R,5S)-フルバスタチンTERT-ブチルエステル |
194934-96-8 |
C28H34FNO4 |
 |
Gefitinib impurity N |
|
|
 |
Ticagrelor Impurity 114 |
|
|
 |
delphinidin 3-O-beta-D-glucoside |
50986-17-9 |
C21H21O12+ |
![4-[[2-(2-Amino-4-thiazolyl)acetyl]amino]-benzeneacetic Acid](/CAS/20200119/GIF/CB24972787.gif) |
4-[[2-(2-Amino-4-thiazolyl)acetyl]amino]-benzeneacetic Acid |
1365244-64-9 |
C13H13N3O3S |
 |
Oseltamivir Impurity L |
|
|
 |
Revefenacin ImpurityABCDEFGHJKL |
|
|
 |
Piperacillin Impurity P |
|
|
 |
ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate |
473465-11-1 |
C18H18N2O3S |
 |
3,3'-(oxybis(ethane-1,1-diyl))bis(1,2-dimethylbenzene) |
|
C20H26O |
 |
Hyoscine Butylbromide EP Impurity G |
|
|
![Benzamide, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-6,8-dithioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl-](/CAS/20210305/GIF/2649802-40-2.gif) |
Benzamide, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-6,8-dithioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl- |
2649802-40-2 |
C21H15F4N5OS2 |
 |
Ornidazole Impurity 1 |
1100750-18-2 |
|
 |
Α,Α-ジフェニル-4-ピペリジノメタノール塩酸塩 |
1798-50-1 |
C18H22ClNO |
 |
N-((2-(5-methyl-4-phenylisoxazol-3-yl)phenyl)sulfonyl)propionamide |
2304623-38-7 |
C19H18N2O4S |
 |
Furosemide Impurity 8 |
41332-59-6 |
C7H4Cl2O5S |
 |
Olaparib Impurity 30 |
1460272-52-9 |
C24H21FN4O4 |
 |
Cefminox Impurity E |
|
|
 |
isorhamnetin 7-O-beta-D-glucopyranoside |
6743-96-0 |
C22H22O12 |
 |
Atracurium Impurity R |
|
|
 |
Oseltamivir Impurity 106 |
|
|
 |
2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil |
1185256-03-4 |
C33H34N6O6 |
 |
tert-butyl 2-((4R,6S)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl- 4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate |
947249-30-1 |
C40H47FN2O5 |
 |
2-メチル-4,5-ジニトロ-1H-イミダゾール |
19183-16-5 |
C4H4N4O4 |
 |
SulbactaM IMpurity C |
|
|
 |
Demiditraz IMpurity |
944268-65-9 |
C20H20N2 |
 |
Abiraterone Sulfate |
|
|
 |
3-(2-アミノエチル)-N-メチル-1H-インドール-5-メタンスルホンアミド |
88919-22-6 |
C12H17N3O2S |
 |
Vonoprazan Impurity 4 |
|
|
 |
Gliclazide Impurity A |
|
|
 |
Linagliptin Impurity 29 |
2074688-82-5 |
C58H58N16O6 |
 |
8-Desacetyl-8-carboxy Daunorubicin Hydrochloride |
58199-96-5 |
C26H27NO11.ClH |
 |
4,4'-Iminodiphenol hydrochloride |
1965310-24-0 |
C12H12ClNO2 |
 |
Bisoprolol Impurity 42 |
|
|
 |
Acetamide,N-(2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)- |
6118-65-6 |
C10H8N2O3 |
 |
エリスラロサミン |
546-57-6 |
C29H49NO8 |
 |
Tetracyclics compound impurities |
|
|
 |
Paxlovid Impurity 20 |
|
|
 |
3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid |
61260-15-9 |
C10H11O5P |
 |
Lasmiditan Impurity 5 |
|
|
![2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine](/CAS/20150408/GIF/877858-27-0.gif) |
2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine |
877858-27-0 |
C12H12N2O |
 |
フェニル(3-クロロフェニル)クロロメタン |
13391-39-4 |
C13H10Cl2 |
![(1R)-1-[(3,4-ジメトキシフェニル)メチル]-6,7-ジメトキシ-2-メチル-1,2,3,4-テトラヒドロイソキノリン](/CAS/20200331/GIF/85-63-2.gif) |
(1R)-1-[(3,4-ジメトキシフェニル)メチル]-6,7-ジメトキシ-2-メチル-1,2,3,4-テトラヒドロイソキノリン |
85-63-2 |
C21H27NO4 |
![6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/20180703/GIF/1812890-23-5.gif) |
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine |
1812890-23-5 |
C13H21N5 |
 |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (minocycline) |
|
|
 |
Peramivir Impurity 31(R) |
|
|
 |
AzithroMycin IMpurity O |
|
|
![Benzenesulfonamide, N-(2-aminoethyl)-3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxy-](/CAS/20210305/GIF/448184-52-9.gif) |
Benzenesulfonamide, N-(2-aminoethyl)-3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxy- |
448184-52-9 |
C19H26N6O4S |
 |
Brivaracetam Impurity 99 |
|
|
 |
Canagliflozin impurities 16 drops |
|
|
 |
Canagliflozin Impurity 39 |
|
|
 |
Trifluridine Impurity 1 |
|
|
 |
Avibactam Impurity 45 |
2064219-20-9 |
C23H46N4O6S |
 |
Topiroxostat Impurity 3 |
|
|
 |
Canagliflozin Impurity 25 |
|
|
 |
CarfilzoMib IMpurity |
1541171-65-6 |
C41H61N5O10S |
 |
5-(Ethoxycarbonyl)-2-(hydroxyMethyl-6-Methyl-4-(3-nitrophenyl)nicotinic Acid |
89267-43-6 |
C17H16N2O7 |
![4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-((5-methylpyridin-3-yl)methyl)piperidine 1-oxide](/) |
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-((5-methylpyridin-3-yl)methyl)piperidine 1-oxide |
|
|
![N-(3-{[(4-methylphenyl)sulfonyl]amino}phenyl)acetamide](/CAS/20180601/GIF/329941-39-1.gif) |
N-(3-{[(4-methylphenyl)sulfonyl]amino}phenyl)acetamide |
329941-39-1 |
C15H16N2O3S |
 |
pidotiMod iMpurity A |
|
|
 |
Cefminox Sodium impurity F |
|
|
![1H-Dibenz[e,g]indole-1-heptanoic acid, 9-fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-3-[(phenylamino)carbonyl]-, (βR,δR)-](/CAS/20210305/GIF/1046533-62-3.gif) |
1H-Dibenz[e,g]indole-1-heptanoic acid, 9-fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-3-[(phenylamino)carbonyl]-, (βR,δR)- |
1046533-62-3 |
C33H33FN2O6 |
 |
Posaconazole Impurity 9 |
|
|
![2,2'-Methylene Bis[Ranitidine]](/CAS/GIF/207592-21-0.gif) |
2,2'-Methylene Bis[Ranitidine] |
207592-21-0 |
C27H44N8O6S2 |
![1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)-](/CAS/20180527/GIF/1404559-22-3.gif) |
1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)- |
1404559-22-3 |
C27H38N6O3S |
 |
Linagliptin MethyldiMer |
1418133-47-7 |
C50H56N16O4 |
 |
9-(2,5-d|Dioxo-L-3-aMino-1-pyrrolidineacetic acid)-10-deglycine DaptoMycin |
121869-35-0 |
C72H99N17O25 |
 |
4a(2H)-Isoquinolinol, octahydro-4-(4-methoxyphenyl)-2-methyl- |
2568340-30-5 |
C17H25NO2 |
 |
Oseltamivir Impurity 30 |
|
|
 |
Sugammadex sodium starting material Impurity 1 |
|
|
 |
1,?4-?Piperazinediacetamid?e, N1,?N4-?dimethyl-?N1,?N4-?bis(4-?nitrophenyl)?- |
2410649-54-4 |
C22H26N6O6 |
 |
Peramivir Impurity 21 |
|
|
 |
CINACALCET-001-R |
1630761-22-6 |
C11H11BF4N4O |
 |
Gefitinib Impurity Q |
|
|
 |
Celecoxib Impurity 15 |
|
C17H14F3N3O2S |
 |
Roxithromycin h |
|
|
 |
LCZ696(valsartan + sacubitril) impurity 36 |
|
|
 |
Canagliflozin Impurity 7 |
|
|
 |
Solifenacin Impurity 7(Solifenacin EP Impurity D) |
2216750-52-4 |
C31H28N2O |
 |
Lincomycin impurity B |
|
|
 |
Oseltamivir Impurity 71 |
|
|
 |
Nifuratel Impurity 21 |
|
|
![[S-(R*,R*)]-3,3'-Dithiobis[2-methylpropanoic acid]](/CAS/20150408/GIF/65134-74-9.gif) |
[S-(R*,R*)]-3,3'-Dithiobis[2-methylpropanoic acid] |
65134-74-9 |
C8H14O4S2 |
 |
Vonoprazan Impurity 7 |
|
|
 |
Vildagliptin Impurity 25 |
1563006-28-9 |
C7H10N2O2 |
 |
1-(2-クロロエチル)-3-(ジシクロプロピルメチル)尿素 |
54187-03-0 |
C10H17ClN2O |
 |
Atracurium Impurity B |
87046-74-0 |
|
 |
2-エトキシ-4-ホルミルフェニルβ-D-グルコピラノシド |
122397-96-0 |
C15H20O8 |
![rel-(1R,3S,5S)-8-Methyl-8-azabicyclo[3,2,1]oct-6-en-yl-2-hydroxy-2,2-dithiophen-2-yl acetate](/CAS/20211123/GIF/136310-66-2.gif) |
rel-(1R,3S,5S)-8-Methyl-8-azabicyclo[3,2,1]oct-6-en-yl-2-hydroxy-2,2-dithiophen-2-yl acetate |
136310-66-2 |
C18H19NO3S2 |
![benzhydryl (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/) |
benzhydryl (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
 |
Δ-2-CEFODIZIME (〜2:1 C242885 TO C242865) |
120533-30-4 |
C20H20N6O7S4 |
 |
impurity 42 |
|
|
 |
7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III |
95603-44-4 |
C35H38Cl6O14 |
 |
Cabozantinib impurity 57 |
|
|